Bone marrow-derived CMPs and GMPs represent highly functional proangiogenic cells: Implications for ischemic cardiovascular disease

Blood

Volumn 118, Issue 24, 2011, Pages 6461-6464

  Wara, Akm Khyrul ^a   Croce, Kevin ^a   Foo, ShiYin ^b   Sun, Xinghui ^a   Icli, Basak ^a   Tesmenitsky, Yevgenia ^a   Esen, Fehim ^a   Rosenzweig, Anthony ^b   Feinberg, Mark W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIGEL;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROCYTE; HEMATOPOIETIC STEM CELL; LEG ISCHEMIA; LYMPHOID PROGENITOR CELL; MALE; MEGAKARYOCYTE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 83455225455     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-363457     Document Type: Article

References (22)

1. Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis. 2010;209(1):10-17.
2. Gupta R, Losordo DW. Cell therapy for critical limb ischemia: moving forward one step at a time. Circ Cardiovasc Interv. 2011;4(1):2-5.
3. Lawall H, Bramlage P, Amann B. Treatment of peripheral arterial disease using stem and progenitor cell therapy. J Vasc Surg. 2011;53(2):445-453.
4. Kawamoto A, Losordo DW. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med. 2008;18(1):33-37.
5. Losordo DW, Schatz RA, White CJ, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation. 2007;115(25):3165-3172. (Pubitemid 47018140)
6. Losordo DW, Henry T, Schatz RA, et al. Autologous CD34+ cell therapy for refractory angina: 12 month results of the phase II ACT34-CMI study. Circulation. 2010;120:S1132.
7. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302):964-967. (Pubitemid 27087709)
8. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701-705. (Pubitemid 32290358)
9. Werner N, Junk S, Laufs U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res. 2003;93(2):e17-e24.
10. Urbich C, Aicher A, Heeschen C, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005;39(5):733-742. (Pubitemid 41464410)
11. Shelton J, Wang D, Gupta H, Wyss JM, Oparil S, White CR. The neointimal response to endovascular injury is increased in obese Zucker rats. Diabetes Obes Metab. 2003;5(6):415-423. (Pubitemid 37483603)
12. Ii M, Takenaka H, Asai J, et al. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res. 2006;98(5):697-704.
13. Kubota T, Kubota N, Moroi M, et al. Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury. Circulation. 2003;107(24):3073-3080. (Pubitemid 36758982)
14. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781-2786. (Pubitemid 35396976)
15. Urbich C, Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med. 2004;14(8):318-322. (Pubitemid 41110611)
16. Barber CL, Iruela-Arispe ML. The ever-elusive endothelial progenitor cell: identities, functions and clinical implications. [erratum appears in Pediatr Res. 2006;59(5):722]. Pediatr Res. 2006;59(4):26R-32R. (Pubitemid 43740032)
17. Qin G, Ii M, Silver M, et al. Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med. 2006;203(1):153-163. (Pubitemid 43139654)
18. Feinberg MW, Wara AK, Cao Z, et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 2007;26(18):4138-4148. (Pubitemid 47462091)
19. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404(6774):193- 197. (Pubitemid 30154488)
20. Roncalli JG, Tongers J, Renault MA, Losordo DW. Endothelial progenitor cells in regenerative medicine and cancer: a decade of research. Trends Biotechnol. 2008;26(5):276-283.
21. Burt RK, Loh Y, Pearce W, et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases [see comment]. JAMA. 2008;299(8):925-936. (Pubitemid 351397068)
22. Melero-Martin JM, Bischoff J. An in vivo experimental model for postnatal vasculogenesis. Methods Enzymol. 2008;445:303-329.